Calif. company developing bioartificial liver gets $22.5M boost

06/25/2013 | MassDevice.com (Boston)

Vital Therapies has secured $22.5 million in a round of financing from 15 investors. The San Diego company will use the money to further develop its ELAD bioartificial liver, which could provide continuous liver support for patients being treated for hepatitis B, alcohol hepatitis and acute organ failure.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ